Article Menu
- Academic Editor
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Möhring, C.
- Berger, M.
- Sadeghlar, F.
- Zhou, X.
- Zhou, T.
- Monin, M. Benedikt
- Shmanko, K.
- Welland, S.
- Sinner, F.
- Schwacha-Eipper, B.
- Bauer, U.
- Roderburg, C.
- Pirozzi, A.
- Ben Khaled, N.
- Schrammen, P.
- Balcar, L.
- Pinter, M.
- Ettrich, T. J.
- Saborowski, A.
- Berres, M.
- De Toni, E. N.
- Lüdde, T.
- Rimassa, L.
- Ehmer, U.
- Venerito, M.
- Radu, I.
- Schmidt-Wolf, I. G. H.
- Weinmann, A.
- Vogel, A.
- Schmid, M.
- Kalff, J. C.
- Strassburg, C. P.
- Gonzalez-Carmona, M. A.
- on Google Scholar
- Möhring, C.
- Berger, M.
- Sadeghlar, F.
- Zhou, X.
- Zhou, T.
- Monin, M. Benedikt
- Shmanko, K.
- Welland, S.
- Sinner, F.
- Schwacha-Eipper, B.
- Bauer, U.
- Roderburg, C.
- Pirozzi, A.
- Ben Khaled, N.
- Schrammen, P.
- Balcar, L.
- Pinter, M.
- Ettrich, T. J.
- Saborowski, A.
- Berres, M.
- De Toni, E. N.
- Lüdde, T.
- Rimassa, L.
- Ehmer, U.
- Venerito, M.
- Radu, I.
- Schmidt-Wolf, I. G. H.
- Weinmann, A.
- Vogel, A.
- Schmid, M.
- Kalff, J. C.
- Strassburg, C. P.
- Gonzalez-Carmona, M. A.
- on PubMed
- Möhring, C.
- Berger, M.
- Sadeghlar, F.
- Zhou, X.
- Zhou, T.
- Monin, M. Benedikt
- Shmanko, K.
- Welland, S.
- Sinner, F.
- Schwacha-Eipper, B.
- Bauer, U.
- Roderburg, C.
- Pirozzi, A.
- Ben Khaled, N.
- Schrammen, P.
- Balcar, L.
- Pinter, M.
- Ettrich, T. J.
- Saborowski, A.
- Berres, M.
- De Toni, E. N.
- Lüdde, T.
- Rimassa, L.
- Ehmer, U.
- Venerito, M.
- Radu, I.
- Schmidt-Wolf, I. G. H.
- Weinmann, A.
- Vogel, A.
- Schmid, M.
- Kalff, J. C.
- Strassburg, C. P.
- Gonzalez-Carmona, M. A.
Need Help?
Order Article Reprints
Journal: Cancers, 2025
Volume: 17
Number: 972
972
Article:
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study
Authors:
by
Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, Xin Zhou, Taotao Zhou, Malte Benedikt Monin, Kateryna Shmanko, Sabrina Welland, Friedrich Sinner, Birgit Schwacha-Eipper, Ulrike Bauer, Christoph Roderburg, Angelo Pirozzi, Najib Ben Khaled, Peter Schrammen, Lorenz Balcar, Matthias Pinter, Thomas J. Ettrich, Anna Saborowski, Marie-Luise Berres, Enrico N. De Toni, Tom Lüdde, Lorenza Rimassa, Ursula Ehmer, Marino Venerito, Iuliana-Pompilia Radu, Ingo G. H. Schmidt-Wolf, Arndt Weinmann, Arndt Vogel, Matthias Schmid, Jörg C. Kalff, Christian P. Strassburg and Maria A. Gonzalez-Carmonaadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/17/6/972
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Möhring, C.; Berger, M.; Sadeghlar, F.; Zhou, X.; Zhou, T.; Monin, M.B.; Shmanko, K.; Welland, S.; Sinner, F.; Schwacha-Eipper, B.; et al. Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study. Cancers 2025, 17, 972. https://doi.org/10.3390/cancers17060972
Möhring C, Berger M, Sadeghlar F, Zhou X, Zhou T, Monin MB, Shmanko K, Welland S, Sinner F, Schwacha-Eipper B, et al. Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study. Cancers. 2025; 17(6):972. https://doi.org/10.3390/cancers17060972
Chicago/Turabian StyleMöhring, Christian, Moritz Berger, Farsaneh Sadeghlar, Xin Zhou, Taotao Zhou, Malte Benedikt Monin, Kateryna Shmanko, Sabrina Welland, Friedrich Sinner, Birgit Schwacha-Eipper, and et al. 2025. "Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study" Cancers 17, no. 6: 972. https://doi.org/10.3390/cancers17060972
APA StyleMöhring, C., Berger, M., Sadeghlar, F., Zhou, X., Zhou, T., Monin, M. B., Shmanko, K., Welland, S., Sinner, F., Schwacha-Eipper, B., Bauer, U., Roderburg, C., Pirozzi, A., Ben Khaled, N., Schrammen, P., Balcar, L., Pinter, M., Ettrich, T. J., Saborowski, A., ... Gonzalez-Carmona, M. A. (2025). Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study. Cancers, 17(6), 972. https://doi.org/10.3390/cancers17060972
